Delve deeper to find the linksBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39450.701262.3A (Published 10 January 2008) Cite this as: BMJ 2008;336:59
- John H Noble Jr, emeritus professor, State University of New York at Buffalo
- 1508 Rio Grande Loop, Georgetown, TX 78633, USA
The finding by Yank et al of no connection between results in meta-analyses and financial ties is surprising,1 given the greater deficiencies for reporting of harm outcomes among trials that were solely funded by industry (median 56% per trial) than among trials that were not (27%).2 Evidently the Oxman-Guyatt measure of scientific quality of research reviews used by Yank et al cannot capture discrepancies in original …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial